TransMedics Group, Inc. (TMDX): Price and Financial Metrics
TMDX Price/Volume Stats
| Current price | $61.17 | 52-week high | $177.37 |
| Prev. close | $60.88 | 52-week low | $60.40 |
| Day low | $60.65 | Volume | 129,219 |
| Day high | $62.40 | Avg. volume | 1,047,629 |
| 50-day MA | $90.87 | Dividend yield | N/A |
| 200-day MA | $120.89 | Market Cap | 2.05B |
TMDX Stock Price Chart Interactive Chart >
TransMedics Group, Inc. (TMDX) Company Bio
TransMedics Group, Inc. is a commercial stage medical technology company, which engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in October 2018 and is headquartered in Andover, MA.
TMDX Price Returns
| 1-mo | -26.23% |
| 3-mo | -62.93% |
| 6-mo | -56.01% |
| 1-year | -20.80% |
| 3-year | 203.87% |
| 5-year | 228.52% |
| YTD | -22.50% |
| 2023 | 27.88% |
| 2022 | 222.13% |
| 2021 | -3.72% |
| 2020 | 4.68% |
| 2019 | N/A |
Loading social stream, please wait...